VIRTUUS Children's Study

Active, not recruitingOBSERVATIONAL
Enrollment

445

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

May 31, 2024

Study Completion Date

August 31, 2025

Conditions
Renal Transplant RejectionPediatric Kidney DiseaseEnd Stage Renal DiseaseNephropathyBK Virus (Nephropathy)Antibody-mediated RejectionAcute Cellular Graft Rejection
Trial Locations (13)

19104

CHOP, Philadelphia

University of Pennsylvania, Philadelphia

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

55455

University of Minnesota, Minneapolis

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

90027

Children's Hospital Los Angeles, Los Angeles

90095

University of California, Los Angeles

94304

Stanford University, Palo Alto

98105

Seattle Children's Hospital, Seattle

92093-0894

University of California-San Diego, Rady Children's Hospital, La Jolla

20010-291

Children's National Medical Center, Washington D.C.

10065-4805

Joan & Sanford I. Weill Medical College of Cornelle University, New York

V6T 1Z3

Vancouver Children's Hospital, Vancouver

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Children's Hospital of Philadelphia

OTHER

NCT03719339 - VIRTUUS Children's Study | Biotech Hunter | Biotech Hunter